Pollen Allergy Trends and Forecast
The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.
• Lucintel forecasts that, within the therapeutics drug class category, corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.
• Within the allergen type category, inhaled will remain the largest segment due to high growth of respiratory allergies.
• In terms of regions, APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.
Gain valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Pollen Allergy Market
A few important trends observed in the pollen allergy market are driven by changes in demography and technological advancements, including environmental awareness.
• Personalized Allergy Treatments: There is increasing focus on personalized medicine in the treatment of allergic conditions, based on the specific characteristics of each individualÄX%$%Xs genetic makeup and natural environmental exposure. This is improving treatment outcomes and the quality of patientsÄX%$%X lives.
• Digital Health Integration: The rise of digital health tools, including mobile apps and wearable devices, is enhancing pollen allergy management. These technologies help track symptoms, manage medications, and provide real-time pollen forecasts.
• Greater Use of Biologics: There is greater use of drugs in this class, as they act on specific pathways in the allergic response. This allows for better and more selective approaches to treating individuals with severe allergies.
• Awareness of the Impact of the Environment: There is increased awareness regarding the current changes in the environment and their consequences for the levels of exposure to pollen, encouraging strategies for reducing exposure and managing symptoms of allergic reactions.
• Expanding the Basket of Immunotherapy Options: Besides sublingual and allergen immunotherapies, a widening array of immunotherapies is now available for allergy sufferers, offering more viable long-term treatment options and yielding better patient outcomes, which drive the growth of the market.
These changes are reconditioning the pollen allergy market with more personalized, effective, and accessible treatment options. They are increasing awareness and improving management strategies to achieve better patient outcomes.
Recent Developments in the Pollen Allergy Market
The recent developments in the pollen allergy market reflect the growing trend toward effective treatment, treatment personalization, better diagnostic tools, and heightened mass awareness to improve patient care and tackle the growing prevalence of pollen allergy worldwide.
• Advancement in Immunotherapy: Improvements in sublingual and allergen-specific immunotherapies are offering superior long-term treatment options. These technological innovations are leading to increased compliance and reduced intensity of allergy symptoms.
• Increased Adoption of Digital Health Tools: New mobile applications and wearable devices have allowed tracking of pollen levels along with the management of symptoms. These digital tools provide current data and personalized suggestions.
• Development of Biologic Drugs: New biologic treatments targeting specific pathways in allergic reactions are offering advanced options for patients with severe allergies. These drugs are leading to better and more effective treatments.
• Increased Research on Environmental Factors: Research on climate change and environmental pollution effects on pollen amounts is leading to better allergy management approaches. It is also influencing public health policies and treatment methods.
• Increased Allergy Testing: Advanced diagnostics and availability of allergy testing spur development through early detection, personalized treatment plans, better allergy management, and alleviation of the suffering of allergic individuals.
These changes are reshaping the pollen allergy market, where overall improvement in the quality and effectiveness of treatment options compensates for the growing need for personalized and effective allergy management.
Strategic Growth Opportunities for Pollen Allergy Market
The market for pollen allergies offers ample growth opportunities from a strategic standpoint, as reflected in the following areas: application-driven technological developments, increased awareness of the disease, and the associated demand for overall management solutions for allergic conditions.
• Expanding Immunotherapy Services: Developing and expanding immunotherapy services, including sublingual services and allergen-specific therapies, presents significant growth potential. Advanced treatments, which are increasingly favored by patients due to their long-term effectiveness and other associated benefits, include:
• Digital Health Solution Integration: Investment in digital health solutions, such as mobile apps and wearable devices that are minimally invasive for monitoring allergen exposure, along with remote monitoring of patientsÄX%$%X body parameters, holds huge potential to enhance patient engagement in their health and pollen allergy management, providing real-time data and personalized treatment planning.
• Growth in Biologic Treatments: The development and commercialization of biologic drugs for severe allergies is presenting critical growth opportunities. These treatments are targeted and increasingly sought after due to their efficiency.
• Awareness Campaigns: Launching educational campaigns on pollen allergies and available treatments will generate demand and drive the market for companies. Increased public awareness will result in higher adoption rates of solutions for allergy management.
• Emerging Market Penetration: Emerging markets, such as India and China, which are experiencing a rise in allergy prevalence, offer significant growth potential. Tailoring products and services to meet the requirements of emerging markets will capture a large and growing customer base.
The strategic growth opportunities in the pollen allergy market bring innovation, expanded treatment options, and improved patient care. Companies that capitalize on these opportunities are well-positioned to navigate the evolving market.
Pollen Allergy Market Driver and Challenges
The pollen allergy market is driven and challenged by technological developments, economic factors, and regulatory concerns. Proper insight into these factors will help one navigate the market effectively.
The factors responsible for driving the pollen allergy market include:
• Technological developments: New diagnosis and treatment methods, such as biologics and digital health solutions, are driving growth in the market. These innovations offer better approaches to dealing with pollen allergies and treating them.
• Increased incidence of allergies: Due to the global increase in pollen allergies, the demand for better treatment and management is likely to rise. This, in turn, will increase the market size and investment in allergy research.
• Government initiatives: Support for allergy research through subsidies and public health campaigns by the government helps establish market growth. Policies to improve allergy management and treatment solutions influence market dynamics.
• Increasing public awareness: Increased awareness of pollen allergies and various treatment methods is aiding the acceptance of solutions for allergy management. Public education has played a key role in raising awareness.
• Market penetration due to expansion of healthcare access: Access to healthcare services and treatment for allergy management, particularly in fast-growing or emerging markets, is poised to drive market growth. This is also making efficient solutions for allergy management more widely available.
Challenges in the pollen allergy market include:
• High treatment costs: The cost of highly developed allergy treatments, such as biologics and immunotherapy, is unaffordable for some patients. This presents a challenge to growth and adoption, especially in lower-income regions.
• Regulatory hurdles: New drugs and technologies face strict regulatory requirements, which delay market entry and increase development costs. Adhering to these regulations is one of the key challenges companies in the allergy market face.
• Variability of allergic reactions: The complexity of individual allergic reactions has made finding a common treatment approach difficult. Variability influences the effectiveness of treatments, thereby affecting market growth.
These drivers and challenges are pivotal forces shaping the pollen allergy market. They not only determine the development of new treatments but also influence market dynamics and the accessibility of care for patients. Addressing these elements will be a key factor in the emergence of companies in this evolving market.
List of Pollen Allergy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-
• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan
Pollen Allergy by Segment
The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.
Pollen Allergy Market by Therapeutics Drug Class [Analysis by Value from 2018 to 2030]:
• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy
Pollen Allergy Market by Product Type [Analysis by Value from 2018 to 2030]:
• Instruments
• Consumables
• Services
Pollen Allergy Market by Allergen Type [Analysis by Value from 2018 to 2030]:
• Food
• Inhaled
• Drug
• Others
Pollen Allergy Market by End Use [Analysis by Value from 2018 to 2030]:
• Diagnostic Laboratories
• Hospitals
• Others
Pollen Allergy Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Pollen Allergy Market
The pollen allergy market is evolving rapidly due to advancements in treatments, changing environmental conditions, and increased awareness of allergic reactions. These developments reflect a broader trend toward personalized and effective management of pollen allergies across different regions.
• United States: Over the past few years, new treatments for allergies, such as sublingual immunotherapy (SLIT) and new biologic medications, have grown in the U.S., aiding the management of pollen allergies. Increased public awareness and new digital health tools also help manage the allergy.
• China: In China, advanced allergy testing and immunotherapy options are becoming more prevalent. Increasing allergy prevalence, government interest in allergy research and treatment, and high pollen counts in urban areas due to climate change are driving market growth.
• Germany: Germany is at the forefront of advancing precision medicine for allergy management through personalized immunotherapy and improved diagnostic tools. The country also focuses on environmental policies to reduce pollen exposure and improve allergy management.
• India: Awareness of allergy treatments is increasing as more treatments become available. Rising pollen allergies and the availability of treatments at reasonable prices contribute to the marketÄX%$%Xs growth. Additionally, the country is focusing on improving diagnostic capabilities and health education for the public.
• Japan: Japan is focusing on more sophisticated allergen-specific immunotherapy and nasal sprays. Recently, the integration of digital health technologies that help track symptoms and manage them has been gaining traction. Increased research and development are expected to make treatments more specific for pollen allergies.
Features of the Global Pollen Allergy Market
Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).
Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the pollen allergy market size?
Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.
Q2. What is the growth forecast for pollen allergy market?
Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the pollen allergy market?
Answer: The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.
Q4. What are the major segments for pollen allergy market?
Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.
Q5. Who are the key pollen allergy market companies?
Answer: Some of the key pollen allergy companies are as follows:
• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan
Q6. Which pollen allergy market segment will be the largest in future?
Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.
Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Pollen Allergy Market, Pollen Allergy Market Size, Pollen Allergy Market Growth, Pollen Allergy Market Analysis, Pollen Allergy Market Report, Pollen Allergy Market Share, Pollen Allergy Market Trends, Pollen Allergy Market Forecast, Pollen Allergy Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.